Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

about

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

Item

http://www.wikidata.org/entity/Q42053469

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@en

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@nl

type

Item

label

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@en

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@nl

prefLabel

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@en

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@nl

P1476

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy.

@en

P2093

Kerri Jack

http://www.w3.org/2001/XMLSchema#string

Khanh Nguyen

http://www.w3.org/2001/XMLSchema#string

Weijing Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols

Nutrition and metabolism in hepatocellular carcinoma

Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions

Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?

Cancer statistics, 2015

Sorafenib in advanced hepatocellular carcinoma

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma pathogenesis: from genes to environment

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

P31

scholarly article

P356

10.3390/DISEASES4010001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288699338

http://www.w3.org/2001/XMLSchema#string

P698

28933381

http://www.w3.org/2001/XMLSchema#string

P932

5456309

http://www.w3.org/2001/XMLSchema#string